Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas

Human Pathology

Volumn 52, Issue , 2016, Pages 1-8

  Thies, Svenja ^a   Guldener, Lars ^a   Slotta Huspenina, Julia ^b   Zlobec, Inti ^a   Koelzer, Viktor H ^a   Lugli, Alessandro ^a   Kröll, Dino ^a   Seiler, Christian A ^a   Feith, Marcus ^c   Langer, Rupert ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenocarcinoma; Cytokeratin; Esophagus; Impact; Tumor budding

Indexed keywords

ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PERINEURAL INVASION; TUMOR BUDDING; TUMOR INVASION; ADENOCARCINOMA; BIOPSY; CHEMISTRY; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; ESOPHAGEAL NEOPLASMS; GERMANY; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; ODDS RATIO; PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; SECONDARY; STAINING; STATISTICAL MODEL; SWITZERLAND;

COLORING AGENT; EOSIN; HEMATOXYLIN; KERATIN; TUMOR MARKER;

ADENOCARCINOMA; BIOMARKERS, TUMOR; BIOPSY; CHI-SQUARE DISTRIBUTION; COLORING AGENTS; EOSINE YELLOWISH-(YS); ESOPHAGEAL NEOPLASMS; GERMANY; HEMATOXYLIN; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KERATINS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; OBSERVER VARIATION; ODDS RATIO; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING; SWITZERLAND;

EID: 84961182214     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2016.01.016     Document Type: Article

References (30)

1. H. Pohl, B. Sirovich, and H.G. Welch Esophageal adenocarcinoma incidence: Are we reaching the peak? Cancer Epidemiol Biomarkers Prev 19 2010 1468 1470
2. H. Pohl, and H.G. Welch The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst 97 2005 142 146
3. J.H. Rubenstein, and N.J. Shaheen Epidemiology, diagnosis, and management of esophageal adenocarcinoma Gastroenterology 149 2015 302.e1. 317.e1.
4. S.R. DeMeester Adenocarcinoma of the esophagus and cardia: A review of the disease and its treatment Ann Surg Oncol 13 2006 12 30
5. V.H. Koelzer, R. Langer, I. Zlobec, and A. Lugli Tumor budding in upper gastrointestinal carcinomas Front Oncol 2014 4 10.3389/fonc.2014.00216
6. F. Prall Tumour budding in colorectal carcinoma Histopathology 50 2007 151 162
7. A. Lugli, E. Karamitopoulou, and I. Zlobec Tumour budding: A promising parameter in colorectal cancer Br J Cancer 106 2012 1713 1717
8. I. Zlobec, and A. Lugli Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget Oncotarget 1 2010 651 661
9. B. Mitrovic, D.F. Schaeffer, R.H. Riddell, and R. Kirsch Tumor budding in colorectal carcinoma: Time to take notice Mod Pathol 25 2012 1315 1325
10. H. Dawson, and A. Lugli Molecular and pathogenetic aspects of tumor budding in colorectal cancer Front Med (Lausanne) 2015 2 10.3389/fmed.2015.00011
11. H.C. van Wyk, J. Park, C. Roxburgh, P. Horgan, A. Foulis, and D.C. McMillan The role of tumour budding in predicting survival in patients with primary operable colorectal cancer: A systematic review Cancer Treat Rev 41 2015 151 159
12. C.C. Compton Key issues in reporting common cancer specimens: Problems in pathologic staging of colon cancer Arch Pathol Lab Med 130 2006 318 324
13. M. Brown, K. Sillah, E.A. Griffiths, and et al. Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers Histopathology 56 2010 893 899
14. M.S. Landau, S.M. Hastings, T.J. Foxwell, J.D. Luketich, K.S. Nason, and J.M. Davison Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma Mod Pathol 27 2014 1578 1589
15. A. Almangush, M. Karhunen, S. Hautaniemi, T. Salo, and I. Leivo Prognostic value of tumour budding in oesophageal cancer: A meta-analysis Histopathology 68 2016 173 182
16. J.A. Nowak, A. Agoston, Y. Zheng, R. Bueno, R.D. Odze, and A. Srivastava Tumor budding is a predictor of nodal metastasis and tumor recurrence in T1 esophageal adenocarcinoma Mod Pathol 26 supplement 2 2013 169A
17. F.T. Bosman, F. Carneiro, R.H. Hruban, and N.D. Theise WHO Classification of Tumours of the Digestive System 4th ed. 2010 World Health Organization Lyon
18. E. Karamitopoulou, I. Zlobec, V. Kolzer, and et al. Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer Mod Pathol 26 2013 295 301
19. H. Ueno, H. Mochizuki, Y. Hashiguchi, and et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma Gastroenterology 127 2004 385 394
20. M. Horcic, V.H. Koelzer, E. Karamitopoulou, and et al. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer Hum Pathol 44 2013 697 705
21. V.H. Koelzer, I. Zlobec, M.D. Berger, and et al. Tumor budding in colorectal cancer revisited: Results of a multicenter interobserver study Virchows Arch 466 2015 485 493
22. K. Ohtsuki, F. Koyama, T. Tamura, and et al. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma Anticancer Res 28 2008 1831 1836
23. G. Puppa, C. Senore, K. Sheahan, and et al. Diagnostic reproducibility of tumour budding in colorectal cancer: A multicentre, multinational study using virtual microscopy Histopathology 61 2012 562 575
24. K. Tanaka, T. Shimura, T. Kitajima, and et al. Tropomyosin-related receptor kinase B at the invasive front and tumour cell dedifferentiation in gastric cancer Br J Cancer 110 2014 2923 2934
25. E. Karamitopoulou, I. Zlobec, D. Born, and et al. Tumour budding is a strong and independent prognostic factor in pancreatic cancer Eur J Cancer 49 2013 1032 1039
26. K. O'Connor, H.H. Li-Chang, S.E. Kalloger, and et al. Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma Am J Surg Pathol 39 2015 472 478
27. B. Salhia, M. Trippel, K. Pfaltz, and et al. High tumor budding stratifies breast cancer with metastatic properties Breast Cancer Res Treat 150 2015 363 371
28. C. Wang, H. Huang, Z. Huang, and et al. Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma J Oral Pathol Med 40 2011 545 551
29. W.-R. Luo, F. Gao, S.-Y. Li, and K.-T. Yao Tumour budding and the expression of cancer stem cell marker aldehyde dehydrogenase 1 in nasopharyngeal carcinoma Histopathology 61 2012 1072 1081
30. Y. Nakanishi, M. Ohara, H. Doumen, N. Kimura, T. Ishidate, and S. Kondo Correlation between tumor budding and post-resection prognosis in patients with invasive squamous cell carcinoma of the thoracic esophagus World J Surg 35 2011 349 356